Randomized clinical trial of prevention of hydrocephalus after intraventricular hemorrhage in preterm infants: Brain-washing versus tapping fluid

Pediatrics

Volumn 119, Issue 5, 2007, Pages

  Whitelaw, Andrew ^a,b,g   Evans, David ^b   Carter, Michael ^c   Thoresen, Marianne ^a   Wroblewska, Jolanta ^d   Mandera, Marek ^d   Swietlinski, Janusz ^d   Simpson, Judith ^e   Hajivassiliou, Constantinos ^f   Hunt, Linda P ^a   Pople, Ian ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c FRENCHAY HOSPITAL   (United Kingdom)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

^e QUEEN MOTHER S HOSPITAL   (United Kingdom)

^f ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Hydrocephalus; Intraventricular hemorrhage; Neurosurgery; Randomized prospective trial

Indexed keywords

ALTEPLASE; CYTOKINE; GENTAMICIN; VANCOMYCIN;

ARTICLE; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; HYDROCEPHALUS; LATERAL BRAIN VENTRICLE; LAVAGE; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SHUNTING; SURGICAL DRAINAGE; TREATMENT OUTCOME;

CEREBRAL VENTRICLES; DRAINAGE; FEMALE; HUMANS; HYDROCEPHALUS; INFANT, NEWBORN; INFANT, PREMATURE; INTRACRANIAL HEMORRHAGES; IRRIGATION; MALE; SPINAL PUNCTURE; THROMBOLYTIC THERAPY; VENTRICULOSTOMY;

EID: 34248228702     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-2841     Document Type: Article

References (25)

1. Volpe JJ. Neurology of the Newborn. 4th ed. Philadelphia, PA: Saunders; 2001:428-493
2. Murphy BP, Inder TE, Rooks, et al. Posthemorrhagic ventricular dilatation in the premature infant: natural history and predictors of outcome. Arch Dis Child Fetal Neonatal Ed. 2002;87:F37-F41
3. Persson EK, Hagberg G, Uvebrant P. Hydrocephalus prevalence and outcome in a population-based cohort of children born in 1989-1998. Acta Paediatr. 2005;94:726-732
4. Larroche JC. Posthemorrhagic hydrocephalus in infancy. Biol Neonate. 1972;20:287-299
5. Cherian S, Whitelaw A, Thoresen M, Love S. The pathogenesis of neonatal post-hemorrhagic hydrocephalus. Brain Pathol. 2004;14:305-311
6. Heep A, Stoffel-Wagner B, Bartmann P, et al. Vascular endothelial growth factor and transforming growth factor-beta1 are highly expressed in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus. Pediatr Res. 2004;56:768-774
7. Kaiser A, Whitelaw A. Cerebrospinal fluid pressure during posthemorrhagic ventricular dilatation in newborn infants. Arch Dis Child. 1985;60:920-923
8. Savman K, Nilsson UA, Blennow M, Kjellmer I, Whitelaw A. Non-protein-bound iron is elevated in cerebrospinal fluid from preterm infants with posthemorrhagic ventricular dilatation. Pediatr Res. 2001;49:208-212
9. Savman K, Blennow M, Hagberg H, Tarkowski E, Thoresen M, Whitelaw A. Cytokine responses in cerebrospinal fluid from preterm infants with posthaemorrhagic ventricular dilatation. Acta Paediatr. 2002;91:1357-1363
10. Tuli S. Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus. J Neurosurg. 2000;92:31-38
11. Ventriculomegaly Trial Group. Randomised trial of early tapping in neonatal post-hemorrhagic ventricular dilatation. Arch Dis Child. 1990;65:3-10
12. Kennedy CR, Ayers S, Campbell MJ, Elbourne D, Hope P, Johnson A. Randomized, controlled trial of acetazolamide and furosemide in posthemorrhagic ventricular dilatation in infancy: follow-up at 1 year. Pediatrics. 2001;108:597-607
13. Whitelaw A, Saliba E, Fellman V, Mowinckel M-C, Acolet D, Marlow N. A phase 1 study of intraventricular recombinant tissue plasminogen activator for the treatment of posthemorrhagic hydrocephalus. Arch Dis Child Fetal Neonatal Ed. 1996;75:F20-F26
14. Hansen A, Volpe JJ, Goumnerova LC, Madsen JR. Intraventricular urokinase for the treatment of posthemorrhagic hydrocephalus. Pediatr Neurol. 1997;17:213-217
15. Luciano R, Velardi F, Romagnoli C, Papacci P, De Stafano V, Tortorolo G. Failure of fibrinolytic endoventricular treatment to prevent neonatal post-hemorrhagic hydrocephalus. Childs Nerv Syst. 1997;13:73-76
16. De Vries LS, Liem KD, van Dijk K, et al. Early versus late treatment of posthaemorrhagic ventricular dilatation: results of a retrospective study from five neonatal intensive care units in the Netherlands. Acta Paediatr. 2002;91:212-217
17. Findlay JM, Weir BKA, Stollery DE. Lysis of intraventricular hematoma with tissue plasminogen activator: case report. J Neurosurg. 1991;74:455-464
18. Rohde V, Schaller C, Hassler WE. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular hemorrhage. J Neurol Neurosurg Psychiatry. 1995;58:447-451
19. Whitelaw A, Pople I, Cherian S, Evans D, Thoresen M. Phase 1 trial of prevention of hydrocephalus after intraventricular hemorrhage in newborn infants by drainage, irrigation, and fibrinolytic therapy. Pediatrics. 2003;111:759-765
20. Levene M. Measurement of the growth of the lateral ventricle in preterm infants with real-time ultrasound. Arch Dis Child. 1981;56:900-904
21. Davies MW, Swaminathan M, Chuang SL, Betheras FR. Reference ranges for linear dimensions of intracranial ventricles in preterm neonates. Arch Dis Child Fetal Neonatal Ed. 2000;82: F218-F223
22. Fenton TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr. 2003;3:13
23. Machin D, Campbell MJ, Fayers PM, Pinol A. Sample Size Tables for Clinical Studies. Oxford, United Kingdom: Blackwell; 1997
24. Lan KK, Wittes J. The B-value: a tool for monitoring data. Biometrics. 1988;44:579-585
25. Proschan MA. Statistical methods for monitoring clinical trials. J Biopharm Stat. 1999;9:599-615